Tumor progression in waiting time for radiotherapy in head and neck cancer

Primdahl, 2006, Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA, Acta Oncol, 45, 156, 10.1080/02841860500423948 Robinson, 2005, Waiting times for radiotherapy: variation over time and between cancer networks in southeast England, Br J Cancer, 92, 1201, 10.1038/sj.bjc.6602463 Rutqvist, 2006, Waiting times for cancer patients – a “slippery slope” in oncology, Acta Oncol, 45, 121, 10.1080/02841860600549204 Barton, 1997, Does waiting time affect the outcome of larynx cancer treated by radiotherapy?, Radiother Oncol, 44, 137, 10.1016/S0167-8140(97)00093-5 Fortin, 2002, Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy, Int J Radiat Oncol Biol Phys, 52, 929, 10.1016/S0360-3016(01)02606-2 Huang, 2003, Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review, J Clin Oncol, 21, 555, 10.1200/JCO.2003.04.171 Hansen, 2005, Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients, Int J Radiat Oncol Biol Phys, 61, 789, 10.1016/j.ijrobp.2004.07.720 Brouha, 2000, Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma?, Clin Otolaryngol Allied Sci, 25, 215, 10.1046/j.1365-2273.2000.00347.x Overgaard, 1986, Primary radiotherapy of larynx and pharynx carcinoma–an analysis of some factors influencing local control and survival, Int J Radiat Oncol Biol Phys, 12, 515, 10.1016/0360-3016(86)90058-1 Bentzen, 1991, Clinical radiobiology of squamous cell carcinoma of the oropharynx, Int J Radiat Oncol Biol Phys, 20, 1197, 10.1016/0360-3016(91)90228-V Bentzen, 1996, Tumor volume and local control probability: clinical data and radiobiological interpretations, Int J Radiat Oncol Biol Phys, 36, 247, 10.1016/S0360-3016(96)00242-8 Johansen, 2002, Glottic carcinoma–patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients, Radiother Oncol, 63, 257, 10.1016/S0167-8140(02)00118-4 Lindeloev, 1995, The impact of lymph node metastases on the results of treatment by primary radiotherapy and secondary surgery in oropharyngeal cancer, Acta Oncol, 34, 965, 10.3109/02841869509127213 Vergeer, 2006, Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation, Radiother Oncol, 79, 39, 10.1016/j.radonc.2006.03.008 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Nat Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 UICC, TNM classification of Malignant Tumours, 5th edition. 1997. Wildt, 1995, Delay in the diagnosis of oral squamous cell carcinoma, Clin Otolaryngol, 20, 21, 10.1111/j.1365-2273.1995.tb00006.x Crawford, 2002, The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland, BMJ, 325, 196, 10.1136/bmj.325.7357.196 Waaijer, 2003, Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma, Radiother Oncol, 66, 271, 10.1016/S0167-8140(03)00036-7 Wyatt, 2003, The effects of delays in radiotherapy treatment on tumour control, Phys Med Biol, 48, 139, 10.1088/0031-9155/48/2/301 Mackillop, 1996, The effect of delay in treatment on local control by radiotherapy, Int J Radiat Oncol Biol Phys, 34, 243, 10.1016/0360-3016(95)02049-7 Overgaard, 1996, Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers, Sem Rad Oncol, 6, 10, 10.1016/S1053-4296(96)80032-4 Wadsley, 2004, Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer, Int J Radiat Oncol Biol Phys, 60, 1405, 10.1016/j.ijrobp.2004.05.049 Overgaard, 1998, A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5–85, Radiother Oncol, 46, 135, 10.1016/S0167-8140(97)00220-X Overgaard, 2003, Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial, Lancet, 362, 933, 10.1016/S0140-6736(03)14361-9 Bourhis, 2006, Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis, Lancet, 368, 843, 10.1016/S0140-6736(06)69121-6 Dammann, 2005, Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET, Am J Roentgenol, 184, 1326, 10.2214/ajr.184.4.01841326 Withers, 1988, Treatment volume and tissue tolerance, Int J Radiat Oncol Biol Phys, 14, 751, 10.1016/0360-3016(88)90098-3 Bentzen, 2001, Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial, Radiother Oncol, 60, 123, 10.1016/S0167-8140(01)00358-9